Role of the tumor microenvironment in mediating response to anti-angiogenic therapy

Cancer and Metastasis Reviews

Volumn 19, Issue 1-2, 2000, Pages 147-157

  Jung, Young D ^a   Ahmad, Syed A ^a   Akagi, Yoshito ^a   Takahashi, Yutaka ^a   Liu, Wenbiao ^a   Reinmuth, Niels ^a   Shaheen, Raymond M ^a   Fan, Fan ^a   Ellis, Lee M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Angiogenesis; Anti angiogenesis; Endothelial cells; Heterogeneity; Microenvironment; Vascular endothelial growth factor

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; ANGIOGENESIS INHIBITOR; ANGIOPOIETIN; BASIC FIBROBLAST GROWTH FACTOR; INTERLEUKIN 8; MASPIN; PLATELET DERIVED GROWTH FACTOR; THROMBOSPONDIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; CELL DIFFERENTIATION; DRUG EFFICACY; ENDOTHELIUM CELL; GENETIC HETEROGENEITY; GROWTH INHIBITION; NONHUMAN; OXYGEN TRANSPORT; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH; VASCULAR ENDOTHELIUM;

ANGIOGENESIS INHIBITORS; ANIMALS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 0034537566     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026510130114     Document Type: Review

References (73)

1. Vascular endothelial cell differentiation: Organ-specificity and selective affinities as the basis for developing anti-cancer strategies
2. Organ targeting in vivo using phage display peptide libraries
3. Regulation of interleukin-8 expression in human melanoma cells by the organ environment
4. Endothelial cell apoptosis is inhibited by a soluble factor secreted by colon cancer cells
5. Endothelium: A distributed organ of diverse capabilities
6. Heterogeneity of the endothelial cell and its role in organ preference of tumour metastasis
7. Differentiation of endothelial cells: Analysis of the constitutive and activated endothelial cell phenotypes
8. Organ-preference of metastasis. The role of endothelial cell adhesion molecules
9. Organ-related differences in binding of Dolichos biflorus agglutinin to vascular endothelium
10. Lectin binding sites in kidney. A comparative study of 14 animal species
11. Heterogeneity of mouse vascular endothelium. In vitro studies of lymphatic, large blood vessel and microvascular endothelial cells
12. Greater permeability of the neonatal lung. Postnatal changes in surface charge and biochemistry of porcine pulmonary capillary endothelium
13. Purification and characterization of rat bone marrow endothelial cells
14. Endothelial cell heterogeneity in venules of mouse airways induced by polarized inflammatory stimulus
15. Chemotherapy targeted to tumor vasculature
16. Requirement of vascular integrin alpha v beta 3 for angiogenesis
17. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: Implications for anti-angiogenic tumor therapies
18. Openings between defective endothelial cells explain tumor vessel leakiness
19. Angiogenesis in cancer, vascular, rheumatoid and other disease
20. Vasculogenesis
21. Migration and proliferation of endothelial cells in performed and newly formed blood vessels during tumor angiogenesis
22. How does extracellular matrix control capillary morphogenesis?
23. Inhibition of endothelial cell movement by pericytes and smooth muscle cells: Activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture
24. Direct actions of angiopoietin-1 on human endothelium: Evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors
25. Regulation of plasminogen activator production by endothelial cells: Role in fibrinolysis and local proteolysis
26. SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types
27. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
28. Vascular integrin alpha(v)beta3: A new prognostic indicator in breast cancer
29. Alpha v integrins as receptors for tumor targeting by circulating ligands
30. The distribution of secondary growths in cancer of the breast
31. Organ site-dependent expression of basic fibroblast growth factor in human renal cell carcinoma cells
32. Multiparametric in situ messenger RNA hybridization analysis to detect metastasis-related genes in surgical specimens of human colon carcinomas
33. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer
34. The implications of angiogenesis to the biology and therapy of cancer metastasis
35. What is the evidence that tumors are angiogenesis dependent?
36. Vasculogenesis in the early quail blastodisc as studied with a monoclonal antibody recognizing endothelial cells
37. Alterations in the protein composition and surface structure of human endothelial cells during growth in primary culture
38. The adhesion of different cell types to cultured vascular endothelium: Effects of culture density and age
39. The formation of fenestrations and channels by capillary endothelium in vitro
40. Induction of blood-brain barrier endothelial cell differentiation
41. A cell culture model of the blood-brain barrier
42. Isolation and culture of high endothelial cells from rat lymph nodes
43. Site-dependent expression of vascular endothelial growth factor, angiogeneisis and proliferation in human gastric carcinoma
44. Differential expression of VEGF in primary and metastatic colon cancers
45. Cytokine networks in solid human tumors: Regulation of angiogenesis
46. Regulation of vascular endothelial growth factor expression in human colon cancer by insulin-like growth factor-I
47. Vascular endothelial growth factor in human glioma cell lines: Induced secretion by EGF, PDGF-BB, and bFGF
48. Effect of lactate, pyruvate, and pH on secretion of angiogenesis and mitogenesis factors by macrophages
49. Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic
50. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia
51. Vascular endothelial growth factor is induced by long-term high glucose concentration and up-regulated by acute glucose deprivation in cultured bovine retinal pigmented epithelial cells
52. Modulation of VEGF production by pH and glucose in retinal Muller cells
53. Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis: Role of infiltrating cells
54. Melanoma-induced epidermal hyperplasia and increased angiogenesis is mediated by TFG-a through down regulation of IFN-B
55. Regulation of tumor angiogenesis by organ-specific cytokines
56. Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas
57. Hyperplastic mucosa adjacent to human colon cancer predicts metastatic potential
58. Modulation of the organ microenvironment for treatment of cancer metastasis
59. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors
60. Therapeutic synergy of TNP-470 and ionizing radiation: Effects on tumor growth, vessel morphology, and angiogenesis in human glioblastoma multiforme xenografts
61. Vascular endothelial growth factor and lym
62. Antiangiogenic therapy targeting the tyrosine kinase receptor for vascular endothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis
63. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
64. Wide spectrum of antitumor-activity of a neutralizing monoclonal antibody to human vascular endothelial growth factor
65. In vivo inhibition of angiogenesis and growth of the human U-87 malignant glial tumor by treatment with an antibody against basic fibroblast growth factor
66. A monoclonal antibody to human angiogenin suppresses tumor growth in athymic mice
67. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
68. Phase I and clinical evaluation of a pharmacologically guided regimen of suramin in patients with hormone-refractory prostate cancer
69. Prognostic factors in carcinoma of the colon and rectum
70. Adenocarcinoma of the stomach: Review of 1497 cases
71. The physiology of the breast as it concerns the clinician
72. Clinical presentation, natural history and prognostic factors in advanced malignant melanoma